Clin2
NCT07590284Possibly a fitNot yet recruiting

Ultrasound contrast for early liver cancer in cirrhosis

Liver CirrhosisLiver Fibrosis

Part of Digestive system clinical trials.

This study tests if a special ultrasound contrast agent can help find liver cancer earlier in people with cirrhosis. It compares this method with other imaging tests to improve early detection and treatment planning.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
556 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have cirrhosis (liver scarring) from any cause, such as hepatitis, alcohol, or other conditions.
  • You are between 18 and 80 years old.
  • You can have regular imaging tests like ultrasound and CT or MRI scans.
  • You have not been diagnosed with liver cancer before, or if you have, it has been treated and cured.
  • You are not allergic to contrast agents or eggs, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07492862Not yet recruiting
Ultrasound test for diagnosing a rare liver blood vessel disorder

This study uses a special ultrasound with contrast to help tell apart two conditions that cause high blood pressure in the liver: porto-sinusoidal vascular disorder (a rare disease of the liver's small blood vessels) and cirrhosis (scarring of the liver). The test may help avoid the need for a liver biopsy.

Roma, RM
NCT07010588Not yet recruiting
Ultrasound and MRI screening for early liver cancer detection

This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.

Beijing, Beijing Municipality
NCT07101237Recruiting
Precision diagnosis and treatment study for liver cancer

This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.

Beijing
NCT06184152Recruiting
Comparing two scans to find liver cancer early

This trial compares two types of imaging scans (CEUS and AMRI) to see which one is better at finding liver cancer (HCC) in patients who have an unclear spot on their liver (an indeterminate nodule). It is for people with cirrhosis who have at least one such nodule but no confirmed liver cancer yet.

Ann Arbor, Michigan
NCT06876805Recruiting
Ultrasound contrast to check unclear liver spots

This trial uses a special ultrasound with contrast dye to get a clearer picture of liver spots that other scans (CT, MRI, or PET) couldn't fully identify. The goal is to see if this ultrasound can help doctors make a more accurate diagnosis.

Bologna
NCT06345508Recruiting
Finding liver cancer early with ultrasound

This study tests a new ultrasound technique to catch liver cancer sooner. If you have regular imaging checks for liver cancer or are getting an MRI for a liver spot, you may be able to join.

Montreal, Quebec

Hear when a new Liver Cirrhosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.